AI companies are using machine learning to improve clinical trial design and execution for existing drugs, aiming to accelerate drug development. Current AI applications in clinical trials focus on process optimisation rather than advanced concepts like full trial simulation. The industry is not yet implementing more speculative AI applications in this area.
